6 Oncology Drugs Likely to Receive FDA Approval in 2026: A Clinical and Regulatory Analysis
Each year, the oncology development landscape becomes noisier. Late-stage assets are promoted aggressively, conference headlines amplify early signals,...
14
Jan
23
Sep
Arc Nouvel Showcases Innovation at BioTechX USA in Philadelphia
Arc Nouvel Debuts in Philadelphia at BioTechX USA with an Exhibitor Booth featured in the Start-Up Zone of the conference...
08
Sep
She’s Gone and Done It: The Inspiring Journey of Dr. Nageatte Ibrahim
At the crossroads of medicine, science, and innovation stands Dr. Nageatte Ibrahim—a physician, scientist, and global leader whose...
